Exchange AgreementExchange Agreement • October 2nd, 2017 • Mannkind Corp • Pharmaceutical preparations • New York
[ ] (the “Investor”) enters into this Exchange Agreement (this “Agreement”) with MannKind Corporation (the “Company”) on September 29, 2017 whereby the Investor will exchange (the “Exchange”) all of the Company’s Series A Common Stock Purchase Warrants and Series B Common Stock Purchase Warrants (the “Warrants”) owned by the Investor for a specified number of shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”).
